JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

Monday, Mar 23, 2026 8:47 am ET1min read
MREO--

JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

JP Morgan Downgrades Mereo Biopharma to Neutral from Overweight Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet